Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Frontiers in Oncology
|
June 28, 2021
Treatment of Advanced-Stage Large Cell Neuroendocrine Cancer (LCNEC) of the Lung: A Tale of Two Diseases
Tahani Atieh, Chao H Huang
Frontiers in Oncology
|
October 20, 2018
Updates in the Clinical Development of Epacadostat and Other Indoleamine 2,3-Dioxygenase 1 Inhibitors (IDO1) for Human Cancers
Takefumi Komiya, Chao H Huang
Clinical Medicine Insights. Oncology
|
May 3, 2012
The Evolving Role of Maintenance Therapy Using Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) in the Management of Advanced Non-Small-Cell Lung Cancer
Chao H Huang, Benjamin C Powers
Frontiers in Oncology
|
December 16, 2022
Hyperprogressive disease in non-small cell lung cancer treated with immune checkpoint inhibitor therapy, fact or myth?
Alec S Britt, Caitlyn Huang, Chao H Huang
Thoracic Cancer
|
January 28, 2016
Systematic analysis of design and stratification for phase III trials in first-line advanced non-small cell lung cancer
Takefumi Komiya, Raymond P Perez, Kirsten D Erickson, et al.
Thoracic Cancer
|
January 15, 2016
Infrequent chemoradiation-induced acute esophagitis in the Asian population: A meta-analysis of published clinical trials for unresectable stage III non-small cell lung cancer
Takefumi Komiya, Shana L Palla, Feng Wang, et al.
Oncology (Williston Park, N.Y.)
|
March 3, 2011
Lung cancer management in 2010
Apar Kishor Ganti, Chao H Huang, Mark A Klein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 26, 2010
Phase II evaluation of sorafenib in advanced and metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group Study S0420
Stephen K Williamson, James Moon, Chao H Huang, et al.
International Journal of Molecular Sciences
|
January 6, 2018
The Role of Compounds Derived from Natural Supplement as Anticancer Agents in Renal Cell Carcinoma: A Review
Inamul Haque, Arvind Subramanian, Chao H Huang, et al.
Cancers
|
October 16, 2025
Novel <i>MAML2</i> Fusions in Human Malignancy
Takefumi Komiya, Kieran Sweeney, Chao H Huang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Frontiers in Oncology
|
June 28, 2021
Treatment of Advanced-Stage Large Cell Neuroendocrine Cancer (LCNEC) of the Lung: A Tale of Two Diseases
Tahani Atieh, Chao H Huang
Frontiers in Oncology
|
October 20, 2018
Updates in the Clinical Development of Epacadostat and Other Indoleamine 2,3-Dioxygenase 1 Inhibitors (IDO1) for Human Cancers
Takefumi Komiya, Chao H Huang
Clinical Medicine Insights. Oncology
|
May 3, 2012
The Evolving Role of Maintenance Therapy Using Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) in the Management of Advanced Non-Small-Cell Lung Cancer
Chao H Huang, Benjamin C Powers
Frontiers in Oncology
|
December 16, 2022
Hyperprogressive disease in non-small cell lung cancer treated with immune checkpoint inhibitor therapy, fact or myth?
Alec S Britt, Caitlyn Huang, Chao H Huang
Thoracic Cancer
|
January 28, 2016
Systematic analysis of design and stratification for phase III trials in first-line advanced non-small cell lung cancer
Takefumi Komiya, Raymond P Perez, Kirsten D Erickson, et al.
Thoracic Cancer
|
January 15, 2016
Infrequent chemoradiation-induced acute esophagitis in the Asian population: A meta-analysis of published clinical trials for unresectable stage III non-small cell lung cancer
Takefumi Komiya, Shana L Palla, Feng Wang, et al.
Oncology (Williston Park, N.Y.)
|
March 3, 2011
Lung cancer management in 2010
Apar Kishor Ganti, Chao H Huang, Mark A Klein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 26, 2010
Phase II evaluation of sorafenib in advanced and metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group Study S0420
Stephen K Williamson, James Moon, Chao H Huang, et al.
International Journal of Molecular Sciences
|
January 6, 2018
The Role of Compounds Derived from Natural Supplement as Anticancer Agents in Renal Cell Carcinoma: A Review
Inamul Haque, Arvind Subramanian, Chao H Huang, et al.
Cancers
|
October 16, 2025
Novel <i>MAML2</i> Fusions in Human Malignancy
Takefumi Komiya, Kieran Sweeney, Chao H Huang, et al.
Page
of 2